This report was first published by Endpoints News. To see the original version, click here
All but 17 drugmakers avoided a direct demand from President Donald Trump last year to lower their prices significantly.
But that likely won’t last.
您已阅读7%（237字），剩余93%（3262字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。